A device intended to be implanted between two adjacent lumbar spinous processes during a minimally-invasive procedure to decompress neural structures, typically to treat a patient with symptomatic degenerative lumbar spinal stenosis (DLSS). It is typically des
| Company | Devices | Share |
|---|---|---|
| Medtronic Sofamor Danek, Inc. | 21 | 29% |
| Nuvasive, Inc. | 15 | 21% |
| Flospine Llc | 8 | 11% |
| Ldr Spine Usa, Inc. | 7 | 10% |
| Paradigm Spine Gmbh | 5 | 7% |
| Companion Spine France | 5 | 7% |
| Boston Scientific Neuromodulation Corporation | 5 | 7% |
| Surgentec, Llc | 5 | 7% |
| Empirical Spine, Inc. | 1 | 1% |
Company = labeler of record on GUDID. 9 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| NQO | Prosthesis, spinous process spacer/plate | 23 |
| KWP | APPLIANCE, FIXATION, SPINAL INTERLAMINAL | 19 |
| PEK | Spinous process plate | 17 |
| NQO | Prosthesis, Spinous Process Spacer/Plate | 15 |
| PEK | Spinous Process Plate | 15 |
| KWP | Appliance, Fixation, Spinal Interlaminal | 10 |
Use these as the dimensions to specify in a tender line.
72 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Lumbar decompression interspinous spacer", from 9 companies. The largest labeler is Medtronic Sofamor Danek, Inc. with 29% of records.
NQO (Prosthesis, spinous process spacer/plate), KWP (APPLIANCE, FIXATION, SPINAL INTERLAMINAL), PEK (Spinous process plate), NQO (Prosthesis, Spinous Process Spacer/Plate)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add lumbar decompression interspinous spacer to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.